Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Pharmaron Beijing Co., Ltd. Class H
3759Health technology
$6.8B
Market Cap
Shariah Analysis
TBD
Business
Cash
Liabilities
Based on AAOIFI screening standards, Pharmaron Beijing Co., Ltd. Class H appears to be TBD.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)12.37%
Non-Shariah Cash Items
Cash And Cash Equivalents$1.7B
Other Short Term Investments$1.1B
Hedging Assets Current$5.1M
Liabilities (<30%)24.40%
Non-Shariah Liabilities
Long Term Debt$4.4B
Long Term Capital Lease Obligation$401.3M
Current Debt$765M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
